| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...749102H |
| P356 | DOI | 10.1371/JOURNAL.PONE.0049102 |
| P932 | PMC publication ID | 3492303 |
| P698 | PubMed publication ID | 23145084 |
| P5875 | ResearchGate publication ID | 233397213 |
| P2093 | author name string | Sheng-Hsiang Lin | |
| Wen-Chien Ko | |||
| Yau-Sheng Tsai | |||
| Pei-Jane Tsai | |||
| Chia-Ming Chang | |||
| Nan-Yao Lee | |||
| Po-Lin Chen | |||
| Chi-Jung Wu | |||
| Yi-Hui Wu | |||
| Yuan-Pin Hung | |||
| Hsiao-Ju Lin | |||
| Ho-Ching Chang | |||
| P2860 | cites work | Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes | Q24309211 |
| Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1 | Q24802369 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| PPARgamma: a critical determinant of body fat distribution in humans and mice | Q28263303 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed? | Q33983927 | ||
| Impact of genetic variation of PPARgamma in humans | Q34355553 | ||
| Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population | Q35206670 | ||
| Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART era. | Q35370152 | ||
| Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology | Q35975460 | ||
| Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors. | Q50977031 | ||
| Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. | Q51464674 | ||
| Association of Single‐Nucleotide Polymorphism 3 and c.553G>T ofAPOA5with Hypertriglyceridemia after Treatment with Highly Active Antiretroviral Therapy Containing Protease Inhibitors in HIV‐Infected Individuals in Taiwan | Q57610523 | ||
| Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes | Q57639011 | ||
| Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy | Q58377861 | ||
| Impact of Peroxisome Proliferator–activated Receptors γ and δ on Adiposity in Toddlers and Preschoolers in the GENESIS Study | Q59418347 | ||
| Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women | Q73086825 | ||
| HIV-1 in Taiwan | Q79828301 | ||
| Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy | Q79952402 | ||
| Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects | Q80138663 | ||
| Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey) | Q80277747 | ||
| Efavirenz to nevirapine switch in HIV-1-infected patients with dyslipidemia: a randomized, controlled study | Q80499517 | ||
| Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis | Q36145648 | ||
| An RBP4 promoter polymorphism increases risk of type 2 diabetes | Q36800296 | ||
| HIV-associated dyslipidaemia: pathogenesis and treatment | Q37018213 | ||
| Alcohol and race/ethnicity elicit different changes in lipid profiles in HIV-infected individuals receiving highly active antiretroviral therapy | Q37066189 | ||
| Alcohol consumption and lipodystrophy in HIV-infected adults with alcohol problems. | Q37082957 | ||
| Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006 | Q37306091 | ||
| A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity | Q38331543 | ||
| Association of the peroxisome proliferator-activated receptor-gamma2 Pro12Ala but not the C1431T gene variants with lower body mass index in Type 2 diabetes | Q39258427 | ||
| Regulatory SNP in the RBP4 gene modified the expression in adipocytes and associated with BMI. | Q39784286 | ||
| Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia | Q40226584 | ||
| Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis | Q42806100 | ||
| PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats | Q42812978 | ||
| Response to anti-HCV therapy in HIV-HCV-coinfected patients: does the lipid profile really have an effect? | Q42937126 | ||
| Lack of agreement between the plasma lipid-based criteria and apoprotein B for the diagnosis of familial combined hyperlipidemia in members of familial combined hyperlipidemia kindreds | Q43879617 | ||
| Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy | Q44105513 | ||
| Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population | Q44210344 | ||
| Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study. | Q44492237 | ||
| Peroxisome proliferator activating receptor alpha and gamma polymorphisms and metabolic abnormalities in HIV-infected patients receiving highly active antiretroviral therapy: the ANRS CO8 APROCO-COPILOTE study | Q44743443 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection | Q45122233 | ||
| PPARgamma Pro12Ala polymorphism in HIV-1-infected patients with HAART-related lipodystrophy. | Q45965487 | ||
| Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy. | Q45980148 | ||
| Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population | Q46112344 | ||
| The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophy | Q46596347 | ||
| Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation | Q46671380 | ||
| High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey | Q46745909 | ||
| The C161-->T polymorphism in peroxisome proliferator-activated receptor gamma, but not P12A, is associated with insulin resistance in Hispanic and non-Hispanic white women: evidence for another functional variant in peroxisome proliferator-activated | Q46777745 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolic syndrome | Q657193 |
| P304 | page(s) | e49102 | |
| P577 | publication date | 2012-11-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Effects of PPARγ and RBP4 gene variants on metabolic syndrome in HIV-infected patients with anti-retroviral therapy | |
| P478 | volume | 7 |
| Q33904136 | A gene expression estimator of intramuscular fat percentage for use in both cattle and sheep |
| Q92457817 | Influence of curcumin supplementation on metabolic and lipid parameters of people living with HIV/AIDS: a randomized controlled trial |
| Q34803775 | PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study |
| Q64231665 | Relationships of , , and Gene Polymorphisms with Gestational Diabetes Mellitus in a Chinese Population |
| Q28078556 | Serum level and polymorphisms of retinol-binding protein-4 and risk for gestational diabetes mellitus: a meta-analysis |
Search more.